Psychedelics Research FYI: Every Clinical Trial Underway Right Now Involving Public And Private Companies

This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In just a couple of years, psychedelics took the world of investing by storm. What in 2019 was merely a buzzword for investors became a full-fledged industry boasting over 25 public companies, including six (and counting) that list their stock in the Nasdaq. As the space progresses, investors are in search of data points that will enable them to track and compare the progress o